CLINICAL_TRIALS
trial_result
· 2024-11-29
Clinical Trial Update: Phase IIB TL + YCWP + DC in Melanoma [Phase 2]
Summary
A Phase II trial evaluating TL + YCWP + DC in melanoma has completed, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Elios Therapeutics, LLC | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2024-11-29